Invest grants provide longer term core or direct delivery funding for eligible charities that are delivering clear outcomes as a result of their work. These grants are from £10,000 up to a maximum of £25,000 per year for two or three years, with the opportunity for continuation funding for a further period – up to six years in total.
Invest grants fund core organisational costs, meaning those related to the day to day running of a charity. We also fund costs associated with the direct delivery of a charity’s work.
Applications for Invest grants are accepted in set annual rounds.
Enable grants provide a great opportunity to strengthen eligible charities so they can deliver more effectively, and are awarded to eligible charities that have identified clear development areas. Enable grants are up to a total of £15,000 over one or two years, and can reinvigorate charities through funding organisational improvements, development of areas such as leadership and governance, improved systems and demonstrating outcomes. These developments put charities in a stronger position to better deliver services and attract funding.
Enable is not a small grants programme and funds work to support identified development needs. Enable grant cannot fund core costs/existing running costs. The costs of the work must be additional to those you would be incurring anyway.
Applications for Enable grants are accepted on an ongoing basis.
Enhance is a grants plus model offering a range of flexible, ‘in kind’ support in addition to an Invest or Enable grant with the aim of strengthening the effectiveness of those we fund in reaching disadvantaged people. Working with a number of partners, including Lloyds Banking Group, we provide non-financial, tailored support to our grant recipients, drawing on relevant expertise and existing volunteering capability.
Enhance support cannot be applied for. We work with charities that are successful in applying for an Invest or Enable grant, to identify whether support under the Enhance programme is right for them.